Literature DB >> 33089317

Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient.

Ji Hoon Baang1, Christopher Smith2, Carmen Mirabelli3, Andrew L Valesano1,3, David M Manthei4, Michael A Bachman4, Christiane E Wobus3, Michael Adams2, Laraine Washer1, Emily T Martin5, Adam S Lauring1,3.   

Abstract

We describe a case of chronic coronavirus disease 2019 (COVID-19) in a patient with lymphoma and associated B-cell immunodeficiency. Viral cultures and sequence analysis demonstrate ongoing replication of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for at least 119 days. The patient had 3 admissions related to COVID-19 over a 4-month period and was treated twice with remdesivir and convalescent plasma with resolution of symptoms. The patient's lack of seroconversion and prolonged course illustrate the importance of humoral immunity in resolving SARS-CoV-2 infection. This case highlights challenges in managing immunocompromised hosts, who may act as persistent shedders and sources of transmission.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; antibody; evolution; immunocompromise

Year:  2021        PMID: 33089317     DOI: 10.1093/infdis/jiaa666

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  94 in total

1.  The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study.

Authors:  Chiara Sepulcri; Chiara Dentone; Malgorzata Mikulska; Bianca Bruzzone; Alessia Lai; Daniela Fenoglio; Federica Bozzano; Annalisa Bergna; Alessia Parodi; Tiziana Altosole; Emanuele Delfino; Giulia Bartalucci; Andrea Orsi; Antonio Di Biagio; Gianguglielmo Zehender; Filippo Ballerini; Stefano Bonora; Alessandro Sette; Raffaele De Palma; Guido Silvestri; Andrea De Maria; Matteo Bassetti
Journal:  Open Forum Infect Dis       Date:  2021-04-28       Impact factor: 3.835

2.  Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking.

Authors:  Hui Chen; Zhao Li; Sheng Feng; Melissa Richard-Greenblatt; Emily Hutson; Stefen Andrianus; Laurel J Glaser; Kyle G Rodino; Jianing Qian; Dinesh Jayaraman; Ronald G Collman; Abigail Glascock; Frederic D Bushman; Jae Seung Lee; Sara Cherry; Alejandra Fausto; Susan R Weiss; Hyun Koo; Patricia M Corby; Alfonso Oceguera; Una O'Doherty; Alfred L Garfall; Dan T Vogl; Edward A Stadtmauer; Ping Wang
Journal:  Clin Chem       Date:  2021-12-30       Impact factor: 8.327

3.  Preventive Behaviors and Mental Health-Related Symptoms Among Immunocompromised Adults During the COVID-19 Pandemic: An Analysis of the COVID Impact Survey.

Authors:  Jessica Yasmine Islam; Denise Christina Vidot; Amoghvarsha Havanur; Marlene Camacho-Rivera
Journal:  AIDS Res Hum Retroviruses       Date:  2021-04       Impact factor: 2.205

4.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Sequence Characteristics of Coronavirus Disease 2019 (COVID-19) Persistence and Reinfection.

Authors:  Manish C Choudhary; Charles R Crain; Xueting Qiu; William Hanage; Jonathan Z Li
Journal:  Clin Infect Dis       Date:  2022-01-29       Impact factor: 9.079

Review 5.  HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.

Authors:  Will Fischer; Elena E Giorgi; Srirupa Chakraborty; Kien Nguyen; Tanmoy Bhattacharya; James Theiler; Pablo A Goloboff; Hyejin Yoon; Werner Abfalterer; Brian T Foley; Houriiyah Tegally; James Emmanuel San; Tulio de Oliveira; Sandrasegaram Gnanakaran; Bette Korber
Journal:  Cell Host Microbe       Date:  2021-06-03       Impact factor: 31.316

6.  Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019.

Authors:  Ghady Haidar; John W Mellors
Journal:  Clin Infect Dis       Date:  2021-09-15       Impact factor: 9.079

7.  Re-infection with different SARS-CoV-2 clade and prolonged viral shedding in a patient with hematopoietic stem cell transplantation: SARS-CoV-2 Re-infection with different clade.

Authors:  Abeer N Alshukairi; Sherif A El-Kafrawy; Ashraf Dada; Mohamed Yasir; Amani H Yamani; Mohammed F Saeedi; Ahmed Aljohaney; Naif I AlJohani; Husam A Bahaudden; Intikhab Alam; Takashi Gojobori; Aleksandar Radovanovic; Thamir A Alandijany; Norah A Othman; Tagreed L Alsubhi; Ahmed M Hassan; Ahmed M Tolah; Jaffar A Al-Tawfiq; Alimuddin Zumla; Esam I Azhar
Journal:  Int J Infect Dis       Date:  2021-07-18       Impact factor: 3.623

8.  SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment.

Authors:  Michel Drancourt; Sébastien Cortaredona; Cléa Melenotte; Sophie Amrane; Carole Eldin; Bernard La Scola; Philippe Parola; Matthieu Million; Jean-Christophe Lagier; Didier Raoult; Philippe Colson
Journal:  Viruses       Date:  2021-05-12       Impact factor: 5.818

9.  COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment.

Authors:  Michele Clerico; Irene Dogliotti; Andrea Calcagno; Daniele Grimaldi; Sarah Leone; Simone Ragaini; Massimo Boffini; Daniele Caracciolo; Simone Ferrero; Cristina Barbero; Elisa Zanotto; Giacomo Stroffolini; Rossana Cavallo; Mauro Rinaldi; Benedetto Bruno; Federica Cavallo
Journal:  Hemasphere       Date:  2021-06-12

10.  Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.

Authors:  Peyman Taghizadeh; Sadegh Salehi; Ali Heshmati; Seyed Massoud Houshmand; Kolsoum InanlooRahatloo; Forouzandeh Mahjoubi; Mohammad Hossein Sanati; Hadi Yari; Afagh Alavi; Saeid Amel Jamehdar; Soroosh Dabiri; Hamid Galehdari; Mohammad Reza Haghshenas; Amir Masoud Hashemian; Abtin Heidarzadeh; Issa Jahanzad; Elham Kheyrani; Ahmad Piroozmand; Ali Mojtahedi; Hadi Razavi Nikoo; Mohammad Masoud Rahimi Bidgoli; Nayebali Rezvani; Mehdi Sepehrnejad; Arash Shakibzadeh; Gholamreza Shariati; Noorossadat Seyyedi; Seyed MohammadSaleh Zahraei; Iman Safari; Elahe Elahi
Journal:  Virology       Date:  2021-06-19       Impact factor: 3.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.